158 related articles for article (PubMed ID: 18594948)
1. In vivo evaluation of type 2 transglutaminase contribution to the metastasis formation in melanoma.
Di Giacomo G; Lentini A; Beninati S; Piacentini M; Rodolfo C
Amino Acids; 2009 Apr; 36(4):717-24. PubMed ID: 18594948
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of tissue transglutaminase in drug resistant and metastatic breast cancer.
Mehta K; Fok J; Miller FR; Koul D; Sahin AA
Clin Cancer Res; 2004 Dec; 10(23):8068-76. PubMed ID: 15585642
[TBL] [Abstract][Full Text] [Related]
3. Role of transglutaminase 2 in quercetin-induced differentiation of B16-F10 murine melanoma cells.
Forni C; Braglia R; Lentini A; Nuccetelli M; Provenzano B; Tabolacci C; Beninati S
Amino Acids; 2009 Apr; 36(4):731-8. PubMed ID: 18688565
[TBL] [Abstract][Full Text] [Related]
4. Tissue transglutaminase in tumour progression: friend or foe?
Kotsakis P; Griffin M
Amino Acids; 2007 Aug; 33(2):373-84. PubMed ID: 17581697
[TBL] [Abstract][Full Text] [Related]
5. Some lessons from the tissue transglutaminase knockout mouse.
Sarang Z; Tóth B; Balajthy Z; Köröskényi K; Garabuczi E; Fésüs L; Szondy Z
Amino Acids; 2009 Apr; 36(4):625-31. PubMed ID: 18584284
[TBL] [Abstract][Full Text] [Related]
6. Enhancement of transglutaminase activity and polyamine depletion in B16-F10 melanoma cells by flavonoids naringenin and hesperitin correlate to reduction of the in vivo metastatic potential.
Lentini A; Forni C; Provenzano B; Beninati S
Amino Acids; 2007 Jan; 32(1):95-100. PubMed ID: 16699821
[TBL] [Abstract][Full Text] [Related]
7. Transglutaminase 2 limits murine peritoneal acute gout-like inflammation by regulating macrophage clearance of apoptotic neutrophils.
Rose DM; Sydlaske AD; Agha-Babakhani A; Johnson K; Terkeltaub R
Arthritis Rheum; 2006 Oct; 54(10):3363-71. PubMed ID: 17009310
[TBL] [Abstract][Full Text] [Related]
8. Tissue transglutaminase-mediated chemoresistance in cancer cells.
Verma A; Mehta K
Drug Resist Updat; 2007; 10(4-5):144-51. PubMed ID: 17662645
[TBL] [Abstract][Full Text] [Related]
9. Antitumor properties of aloe-emodin and induction of transglutaminase 2 activity in B16-F10 melanoma cells.
Tabolacci C; Lentini A; Mattioli P; Provenzano B; Oliverio S; Carlomosti F; Beninati S
Life Sci; 2010 Aug; 87(9-10):316-24. PubMed ID: 20624404
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of phospho mutant forms of transglutaminase 2 downregulates epidermal growth factor receptor.
Wang Y; Ande SR; Mishra S
Biochem Biophys Res Commun; 2012 Jan; 417(1):251-5. PubMed ID: 22142843
[TBL] [Abstract][Full Text] [Related]
11. Decrease of polyamine levels and enhancement of transglutaminase activity in selective reduction of B16-F10 melanoma cell proliferation induced by atrial natriuretic peptide.
Baldini PM; Lentini A; Mattioli P; Provenzano B; De Vito P; Vismara D; Beninati S
Melanoma Res; 2006 Dec; 16(6):501-7. PubMed ID: 17119451
[TBL] [Abstract][Full Text] [Related]
12. Impairment of the metastatic activity of melanoma cells by transglutaminase-catalyzed incorporation of polyamines into laminin and Matrigel.
Lentini A; Provenzano B; Caraglia M; Shevchenko A; Abbruzzese A; Beninati S
Amino Acids; 2008 Feb; 34(2):251-6. PubMed ID: 17356804
[TBL] [Abstract][Full Text] [Related]
13. Homocysteine-induced toxicity increases TG2 expression in Neuro2a cells.
Currò M; Condello S; Caccamo D; Ferlazzo N; Parisi G; Ientile R
Amino Acids; 2009 Apr; 36(4):725-30. PubMed ID: 18594946
[TBL] [Abstract][Full Text] [Related]
14. Transglutaminase 2 regulates mallory body inclusion formation and injury-associated liver enlargement.
Strnad P; Harada M; Siegel M; Terkeltaub RA; Graham RM; Khosla C; Omary MB
Gastroenterology; 2007 Apr; 132(4):1515-26. PubMed ID: 17408647
[TBL] [Abstract][Full Text] [Related]
15. Transglutaminase-mediated oligomerization of galectin-3 modulates human melanoma cell interactions with laminin.
van den Brûle FA; Liu FT; Castronovo V
Cell Adhes Commun; 1998 Sep; 5(6):425-35. PubMed ID: 9791724
[TBL] [Abstract][Full Text] [Related]
16. Antineoplastic activity of strawberry (Fragaria×ananassa Duch.) crude extracts on B16-F10 melanoma cells.
Forni C; Braglia R; Mulinacci N; Urbani A; Ronci M; Gismondi A; Tabolacci C; Provenzano B; Lentini A; Beninati S
Mol Biosyst; 2014 Jun; 10(6):1255-63. PubMed ID: 24185584
[TBL] [Abstract][Full Text] [Related]
17. Transglutaminase 2: a multi-tasking protein in the complex circuitry of inflammation and cancer.
Mehta K; Kumar A; Kim HI
Biochem Pharmacol; 2010 Dec; 80(12):1921-9. PubMed ID: 20599779
[TBL] [Abstract][Full Text] [Related]
18. Transglutaminase catalyzed dissociation and association of protein-polyamine complex.
Ohtake Y; Nagashima T; Suyama-Satoh S; Maruko A; Shimura N; Ohkubo Y
Life Sci; 2007 Jul; 81(7):577-84. PubMed ID: 17673261
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of B16 melanoma metastases with the ruthenium complex imidazolium trans-imidazoledimethylsulfoxide-tetrachlororuthenate and down-regulation of tumor cell invasion.
Gava B; Zorzet S; Spessotto P; Cocchietto M; Sava G
J Pharmacol Exp Ther; 2006 Apr; 317(1):284-91. PubMed ID: 16368900
[TBL] [Abstract][Full Text] [Related]
20. Transglutaminase 2 inhibitor, KCC009, disrupts fibronectin assembly in the extracellular matrix and sensitizes orthotopic glioblastomas to chemotherapy.
Yuan L; Siegel M; Choi K; Khosla C; Miller CR; Jackson EN; Piwnica-Worms D; Rich KM
Oncogene; 2007 Apr; 26(18):2563-73. PubMed ID: 17099729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
